Evidence map›Paper›PMID 35426806›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[Pirfenidone alleviates urethral stricture following urethral injury in rats by suppressing TGF-β1 signaling and inflammatory response].

Z Li, X Huang, S Chen, Z Zhang, X Liang, H Li, L Qin, Y Guo

Open access · greenAbstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Z LiDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China.
X HuangSchool of Clinical Medicine, Bengbu Medical College, Bengbu 233040, China.
S ChenDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China.
Z ZhangSchool of Clinical Medicine, Bengbu Medical College, Bengbu 233040, China.
X LiangDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China.
H LiDepartment of Cardiothoracic Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China.
L QinDepartment of Radiology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China.
Y GuoDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu 233040, China.
Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of pirfenidone for reducing urethral stricture following urethral injury in rats and explore the possible mechanism.

methodsThirty male SD rats were randomly assigned into negative control group, positive control group and pirfenidone group (

resultsThe body weight of the rats in pirfenidone group was significantly decreased compared with that in the other two groups (

conclusionPirfenidone can prevent urethral fibrosis and stricture after urethral injury possibly by inhibiting the TGF-β1 pathway and inflammatory response.

Indexed as

PyridonesTransforming Growth Factor beta1Urethral StrictureAnimalsFemaleHumansInterleukin-6MaleRatsRats, Sprague-DawleyRNA, MessengerSolventsTumor Necrosis Factor-alphaInterleukin-6pirfenidonePyridonesRNA, MessengerSolventsTransforming Growth Factor beta1Tumor Necrosis Factor-alphafibrosisinflammationpirfenidonetransforming growth factor-β1urethra stricture

Identifiers

PMID35426806
PMCPMC9010994
OpenAlexW4224124414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.